Cargando…
Fibrinolysis Shutdown and Thrombosis in Severe COVID-19
Autores principales: | Seheult, Jansen N., Seshadri, Anupamaa, Neal, Matthew D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American College of Surgeons. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290169/ https://www.ncbi.nlm.nih.gov/pubmed/32593497 http://dx.doi.org/10.1016/j.jamcollsurg.2020.05.021 |
Ejemplares similares
-
Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection
por: Wright, Franklin L., et al.
Publicado: (2020) -
Fibrinolysis Shutdown in COVID-19-Associated Coagulopathy: A Crosstalk among Immunity, Coagulation, and Specialists in Medicine and Surgery
por: Walsh, Mark M., et al.
Publicado: (2021) -
Fibrinolysis Shutdown in COVID-19: Clinical Manifestations, Molecular Mechanisms, and Therapeutic Implications
por: Meizoso, Jonathan P., et al.
Publicado: (2021) -
Hyperfibrinolysis and fibrinolysis shutdown in patients with traumatic brain injury
por: Nakae, Ryuta, et al.
Publicado: (2022) -
Do not drink and lyse: alcohol intoxication increases fibrinolysis shutdown in injured patients
por: Stettler, Gregory R., et al.
Publicado: (2020)